Published in
Elsevier, Annals of Oncology, 12(22), p. 2661-2666, 2011
Links
- ORCID
- Elsevier
- ORCID
- [www.ncbi.nlm.nih.gov] | PDF
- [europepmc.org] | PDF
- [www.researchgate.net]
- [www.ncbi.nlm.nih.gov] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
Pilot trial of sunitinib therapy in patients with von Hippel–Lindau disease
Journal article published in 2011 by
E. Jonasch,
I. E. McCutcheon,
S. G. Waguespack 
,
S. Wen,
D. W. Davis,
Smith La,
L. A. Smith,
N. M. Tannir,
D. S. Gombos ,
G. N. Fuller,
S. F. Matin
,
S. Wen,
D. W. Davis,
Smith La,
L. A. Smith,
N. M. Tannir,
D. S. Gombos ,
G. N. Fuller,
S. F. Matin
This paper is available in a repository.
Full text: Download
Published version:
archiving forbidden
Data provided by 
Abstract
Background: Von Hippel–Lindau (VHL) disease induces vascular neoplasms in multiple organs. We evaluated the safety and efficacy of sunitinib in VHL patients and examined the expression of candidate receptors in archived tissue.